Tetrazole derivatives
    1.
    发明授权
    Tetrazole derivatives 失效
    四唑衍生物

    公开(公告)号:US6117886A

    公开(公告)日:2000-09-12

    申请号:US357156

    申请日:1999-07-19

    CPC分类号: C07D401/14

    摘要: The present invention is directed to a tetrazole derivative represented by the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 independently represent a hydrogen atom, a hydroxyl group, a lower alkyl group, a substituted or unsubstituted alkoxy group, or a substituted or unsubstituted alkanoyloxy group; R.sup.3 represents a hydrogen atom or a substituted or unsubstituted lower alkyl group; A represents a methyleneoxy group or a vinylene group; Z represents a substituted or unsubstituted benzimidazolyl group; and a broken line indicates that there may be a double bond; and to a medicine containing the compound as an active ingredient. The medicine according to the present invention is endowed with excellent antileukotriene activity and antihistaminic activity, and is useful for the prevention and treatment of, for example, asthma.

    摘要翻译: 本发明涉及由下式(1)表示的四唑衍生物或其盐:其中R1和R2独立地表示氢原子,羟基,低级烷基,取代或未取代的烷氧基或 取代或未取代的烷酰氧基; R3表示氢原子或取代或未取代的低级烷基; A表示亚甲氧基或亚乙烯基; Z表示取代或未取代的苯并咪唑基; 虚线表示可能存在双键; 和含有该化合物作为活性成分的药物。 根据本发明的药物具有优异的抗白三烯活性和抗组胺活性,可用于预防和治疗例如哮喘。

    Tetrazole derivatives
    2.
    发明授权
    Tetrazole derivatives 失效
    四唑衍生物

    公开(公告)号:US6121286A

    公开(公告)日:2000-09-19

    申请号:US158774

    申请日:1998-09-23

    CPC分类号: C07D401/14

    摘要: The present invention is directed to a tetrazole derivative represented by the following formula (1) or a salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 independently represent a hydrogen atom, a hydroxyl group, a lower alkyl group, a substituted or unsubstituted alkoxy group, or a substituted or unsubstituted alkanoyloxy group; R.sup.3 represents a hydrogen atom or a substituted or unsubstituted lower alkyl group; A represents a methyleneoxy group or a vinylene group; B represents a substituted or unsubstituted quinolyl group, a substituted or unsubstituted quinazolyl group, or a substituted or unsubstituted benzimidazolyl group; and a broken line indicates that there may be a double bond; and to a medicine containing the compound as an active ingredient. The medicine according to the present invention is endowed with excellent antileukotriene activity and antihistaminic activity, and is useful for the prevention and treatment of, for example, asthma.

    摘要翻译: 本发明涉及由下式(1)表示的四唑衍生物或其盐:其中R1和R2独立地表示氢原子,羟基,低级烷基,取代或未取代的烷氧基或 取代或未取代的烷酰氧基; R3表示氢原子或取代或未取代的低级烷基; A表示亚甲氧基或亚乙烯基; B表示取代或未取代的喹啉基,取代或未取代的喹唑基,或取代或未取代的苯并咪唑基; 虚线表示可能存在双键; 和含有该化合物作为活性成分的药物。 根据本发明的药物具有优异的抗白三烯活性和抗组胺活性,可用于预防和治疗例如哮喘。

    Diamine derivatives and pharmaceutical containing the same
    4.
    发明授权
    Diamine derivatives and pharmaceutical containing the same 失效
    二胺衍生物和含有相同的药物

    公开(公告)号:US6127360A

    公开(公告)日:2000-10-03

    申请号:US147777

    申请日:1999-03-05

    摘要: This invention relates to a diamine derivative represented by the following formula (1) or a salt thereof. wherein R.sup.1 represents H, OH, an aralkyloxy group or a halogen atom; R.sup.2 represents H or a lower alkyl group; A represents --C(R.sup.3).dbd.CH--, --CH.dbd.N--, --N(R.sup.4)--, R.sup.3 being H or OH, R.sup.4 being a lower alkyl group or an alkoxyalkyl group, --O--, or --S--; B represents a single bond, --C(R.sup.5)(R.sup.6)--(CH.sub.2).sub.k --, R.sup.5 and R.sup.6 being H or a lower alkyl group, and k being a value of from 0 to 2, --S(O).sub.q CH(R.sup.7), or --CH.dbd.CH--; E represents a single bond or --(CH.sub.2).sub.3 --; W and Y individually represent --CH.sub.2 -- or --CO--; Z represents O or S; and m is a value of 2 or 3, and n is a value of from 1 to 4; with the proviso that E is --(CH.sub.2).sub.3 -- when B is a single bond and E is a single bond when B is a group other than a single bond. The diamine derivatives or salts thereof have both antileukotrienic action and antihistaminic action and are low in brain penetration, and are hence useful as asthma preventives and curatives.

    摘要翻译: PCT No.PCT / JP98 / 03054 Sec。 371日期1999年3月5日 102(e)1999年3月5日PCT PCT 1998年7月7日PCT公布。 公开号WO99 /​​ 02520 日期1999年1月21日本发明涉及由下式(1)表示的二胺衍生物或其盐。 其中R1表示H,OH,芳烷氧基或卤素原子; R2表示H或低级烷基; A表示-C(R3)= CH-,-CH = N-,-N(R4) - ,R3为H或OH,R4为低级烷基或烷氧基烷基,-O-或-S-; B表示单键,-C(R5)(R6) - (CH2)k-,R5和R6是H或低级烷基,k表示0-2,-S(O)qCH( R7)或-CH = CH-; E表示单键或 - (CH 2)3 - ; W和Y各自表示-CH 2 - 或-CO-; Z表示O或S; m为2或3,n为1〜4的值。 条件是当B是单键时E是 - (CH 2)3,当B是除单键以外的基团时,E是单键。 二胺衍生物或其盐具有抗白细胞增多作用和抗组胺作用,并且脑渗透性低,因此可用作哮喘预防剂和固化剂。